BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the close of a $50 ...

Spain-based INBRAIN Neuroelectronics, a company specialising in graphene-based brain-computer interface (BCI) technologies, has secured $50m (€46m) in a Series B financing round, aimed at advancing ...

Image caption: INBRAIN Cortical BCI; Image credit: INBRAIN Neuroelectronics Graphene-based BCI demonstrates high-resolution brain decoding and mapping in patients undergoing tumor resection at the ...

Barcelona-based INBRAIN Neuroelectronics, which offers a graphene-based brain-computer interface (BCI) therapeutics platform, announced a strategic partnership with tech giant Microsoft to advance the ...

BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent ...

Elon Musk has outlandish plans for Neuralink’s brain-computer interfaces, from giving people “superpowers” to downloading their memories. Spanish rival Inbrain Neuroelectronics has a simpler goal: ...

Elon Musk's Neuralink has a new competitor It's a startup company called Inbrain Neuroelectronics It says its chips are made of one of the strongest materials ever tested It aims to cure brain ...

InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic AI to its brain computer-interface (BCI) platform. The strategic partnership ...

The study (NCT06368310), sponsored by the University of Manchester and conducted with Northern Care Alliance NHS Foundation Trust, evaluated INBRAIN’s graphene-based cortical interface during ...

Spanish neurotechnology company INBRAIN Neuroelectronics (InBrain) has concluded patient enrolment for its first-in-human study of a graphene neural interface to advance brain decoding and mapping.

Lille, May 12, 2025 - InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development against neurodegenerative diseases, is thrilled to announce that it has been selected as ...